Item 8.01 Other Events.

On February 12, 2013, Trovagene, Inc. (the "Company") issued a press release announcing commercial launch timelines for its HPV carrier and oncogene mutation tests. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. In addition, the Company is furnishing its corporate presentation as Exhibit 99.2 to this Current Report on Form 8-K.

The information disclosed under this Item 8.01, including Exhibits 99.1 and 99.2 hereto, is being furnished and shall not be deemed "filed" for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, except as expressly set forth in such filing.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits. 99.1 Press Release dated February 12, 2013 99.2 Corporate Presentation dated February 13, 2013

---